Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1093-1099

  Drobyski, W R ^a,c   Potluri, J ^a   Sauer, D ^b   Gottschall, J L ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c Bone Marrow Transplant Program   (United States)

Author keywords

Autoimmunity; Bone marrow transplantation; Cyclosporine; Hemolytic anemia; T cell depletion

Indexed keywords

AUTOANTIBODY; COLD AGGLUTININ; CORTICOSTEROID; ERYTHROCYTE ANTIGEN; ERYTHROPOIETIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; STAPHYLOCOCCUS PROTEIN A;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOCRIT; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; MALE; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; SPLENECTOMY; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030037577     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Foerster J. Autoimmune hemolytic anemia. In: Lee G, Bithell T, Foerster J, (eds). Clinical Hematology. Lea & Febiger: Philadelphia, 1993, pp 1170-1196.
2. Hows J, Beddow K, Gordon-Smith E et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177-181.
3. Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159-170.
4. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534.
5. Frankel S, Cunningham I, Reich L. Autoimmune hemolytic anemia following bone marrow transplantation for chronic myelogenous leukemia. Blood 1989; 74: 226a.
6. Klumpp TR, Caligiuri MA, Rabinowe SN et al. Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 6: 445-447.
7. Tamura T, Kanamori H, Yamazaki E et al. Cold agglutinin disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 13: 321-323.
8. Cohen EP, Lawton CA, Moulder JE et al. Clinical course of late-onset bone marrow transplant nephropathy. Nephron 1993; 64: 626-635.
9. Lawton CA, Cohen EP, Barber-Derus SW et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 1991; 67: 2795-2800.
10. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
11. Waid TH, Lucas BA, Amlot P et al. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection. Am J Kidney Dis 1989; 14: 61-70.
12. Drobyski W, Thibodeau S, Truitt RL et al. Third party-mediated graft rejection and graft-versus-host disease after T-cell depleted bone marrow transplantation as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 1989; 74: 2285-2294.
13. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
14. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
15. Walker RH, Branch DR, Dzik WH, Judd J (eds). American Association of Blood Banks, Technical Manual. American Association of Blood Banks: Bethesda, MD, 1993.
16. Dumaswala UJ, Sukati H, Greenwalt TJ. The protein composition of red cell eluates. Transfusion 1995; 35: 33-36.
17. Gmur JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290-295.
18. Ho WG, Champlin RE, Feig SA, Gale RP. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor bone marrow. Br J Haematol 1984; 57: 155-162.
19. Dinsmore RE, Reich LM, Kapoor N et al. ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation. Br J Haematol 1983; 54: 441-449.
20. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation 1982; 33: 427-429.
21. Warkentin PI, Yomtovian R, Hurd D et al. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation. Vox Sang 1983, 45, 40-47.
22. Hazlehurst GRP, Brenner MK, Wimperis JZ et al. Hemolysis after T cell depleted bone marrow transplantation involving minor ABO incompatibility. Scand J Haematol 1986; 37: 1-3.
23. Gajewski JL, Petz LD, Calhoun L et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated donor bone marrow transplants in patients receiving cyclosporine without post-transplant methotrexate. Blood 1992; 79: 3076-3085.
24. Klump TR, Block CC, Caligiuri MA et al. Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature. Medicine 1992; 71: 73-83.
25. Insel R. Disorders of lymphocyte function. In: Hoffmann R, Berz E, Shattile S (eds). Hematology: Basic Principles and Practice. Churchill Livingstone: New York, 1991, pp 590-603.
26. Moller G. Models of autoimmunity. Immunol Rev 1990; 118: 1-310.
27. Wen L, Roberts SJ, Viney JL et al. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells. Nature 1994; 369: 654-658.
28. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. a study of 53 long-term-surviving patients. Transplantation 1988; 46: 238-240.
29. Rouquette-Gally AM, Boyeldieu D, Gluckman E et al. Comparison of autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987; 66: 45-47.
30. Lister J, Messner H, Keystone E et al. Autoantibody analysis of patients with graft-versus-host disease. J Clin Lab Immunol 1987; 24: 19-23.
31. Okos AJ, Lum LG, Storb R. Epstein-Barr virus (EBV)-induced immunoglobulin (Ig) production and suppression by EBV immune T-cells in bone marrow transplant recipients. Blood 1983; 62: 227a.
32. Parkman R. Clonal analysis of murine graft-versus-host disease. I. Phenotypic and functional analysis of T-cell clones. J Immunol 1986; 136: 3543-3548.
33. Sinha AA, Lopez T, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science 1990; 248: 1380-1388.
34. Gao EK, Loh D, Cheyney R et al. Abnormal differentiation of thymocytes in mice treated with cyclosporine A. Nature 1988; 336: 176-179.
35. Grazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporine A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158: 1-8.
36. + T lymphocyte subsets. J Immunol 1990; 145: 526-533.
37. Small TN, Papadopoulos E, Kernan NA, O'Reilly RJ. Effects on immune reconstitution of unirradiated donor leukocyte infusions for the treatment of prophylaxis of EBV-lymphoproliferative disorders following unrelated bone marrow transplantation. Blood 1993; 82: 214a.